Evidence map›Paper›PMID 40696642›Full record

ArticleMedicine2025

Amlodipine overdose rescued with extracorporeal membrane oxygenation: A case report.

Hong Ding, Hui Wang, Zi-Yan Wang, Yuan-Zheng Liu, Kun Zhang

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hong DingDepartment of Intensive Care, Affiliated Hospital of Chengde Medical University, Chengde, China.
Hui WangDepartment of Intensive Care, Linyi People's Hospital, Linyi, China.
Zi-Yan WangDepartment of Intensive Care, Affiliated Hospital of Chengde Medical University, Chengde, China.
Yuan-Zheng LiuDepartment of Intensive Care, Affiliated Hospital of Chengde Medical University, Chengde, China.
Kun ZhangDepartment of Intensive Care, Affiliated Hospital of Chengde Medical University, Chengde, China.ORCID 0009-0007-8221-5011

Funding

Chengde City Science and Technology Research and Development Program Project (2021) 202109A071
6 · The paper itself

Abstract

rationaleAmlodipine, a calcium channel blocker, is widely prescribed for managing hypertension through vascular smooth muscle relaxation. However, severe amlodipine toxicity can lead to profound hypotension and refractory shock, often unresponsive to conventional treatments. PATIENT CONCERNS: In this report, we reported a 32-year-old female case of amlodipine overdose who was admitted to our hospital on March 1, 2024, due to intentionally ingesting approximately 84 tablets of amlodipine (5 mg each). DIAGNOSES: Patient was diagnosed with amlodipine overdose and refractory shock.

interventionPatient was treated with extracorporeal membrane oxygenation (ECMO), invasive mechanical ventilation, and continuous renal replacement therapy. OUTCOMES: On March 7, the patient was successfully weaned off ECMO and discharged on March 15, 2024. During postoperative follow-up, the lung CT scan showed complete resolution of intrapulmonary exudates. LESSONS: The case prompts that early initiation of ECMO, following the failure of conventional medical interventions, was pivotal in stabilizing the patient's hemodynamics, offering a promising alternative in the management of severe calcium channel blocker toxicity.

Indexed as

AmlodipineCalcium Channel BlockersDrug OverdoseExtracorporeal Membrane OxygenationShockAdultAntihypertensive AgentsFemaleHumansAmlodipineAntihypertensive AgentsCalcium Channel Blockersamlodipinecalcium channel blocker overdoseextracorporeal membrane oxygenationhypotensionrefractory shock

Identifiers

PMID40696642
PMCPMC12282810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.